Asacol
Description
Clinical
Indications
Side Effects
Warnings
OverDosage
Patient Info


SIDE EFFECTS

Clinical Adverse Experience

ROWASA® Rectal Suspension Enema is usually well tolerated. Most adverse effects have been mild and transient.

SIDE EFFECTS

OCCURRING IN MORE THAN 0.1% OF ROWASA® RECTAL SUSPENSION ENEMA TREATED PATIENTS
(COMPARISON TO PLACEBO)


SYMPTOM
ROWASA®
(N= 815)
N
%
PLACEBO
(N= 128)
N
%
Abdominal Pain/ Cramps/ Discomfort

66

8.10

10

7.81

Headache

53

6.50

16

12.50

Gas/ Flatulence

50

6.13

5

3.91

Nausea

47

5.77

12

9.38

Flu

43

5.28

1

0.78

Tired/ Weak/ Malaise/ Fatigue

28

3.44

8

6.25

Fever

26

3.19

0

0.00

Rash/ Spots

23

2.82

4

3.12

Cold/ Sore Throat

19

2.33

9

7.03

Diarrhea

17

2.09

5

3.91

Leg/ Joint Pain

17

2.09

1

0.78

Dizziness

15

1.84

3

2.34

Bloating

12

1.47

2

1.56

Back Pain

11

1.35

1

0.78

Pain on Insertion of Enema Tip

11

1.35

1

0.78

Hemorrhoids

11

1.35

0

0.00

Itching

10

1.23

1

0.78

Rectal Pain

10

1.23

0

0.00

Constipation

8

0.98

4

3.12

Hair Loss

7

0.86

0

0.00

Peripheral Edema

5

0.61

11

8.59

UTI/ Urinary Burning

5

0.61

4

3.12

Rectal Pain/ Soreness/ Burning

5

0.61

3

2.34

Asthenia

1

0.12

4

3.12

Insomnia

1

0.12

3

2.34



In addition, the following adverse events have been associated with ROWASA® Rectal Suspension Enema and other mesalamine containing products: nephrotoxicity, pancreatitis, fibrosing alveolitis and elevated liver enzymes. Cases of pancreatitis and fibrosing alveolitis have been reported as manifestations of inflammatory bowel disease as well.

Hair Loss

Mild hair loss characterized by “more hair in the comb” but no withdrawal from clinical trials has been observed in seven of 815 mesalamine patients but none of the placebo-treated patients. In the literature there are at least six additional patients with mild hair loss who received either mesalamine or sulfasalazine. Retreatment is not always associated with repeated hair loss.

Buy
Asacol Now
 
Buy
Asacol Now